158 related articles for article (PubMed ID: 1302561)
1. Allelic frequency of a p53 polymorphism in human lung cancer.
Weston A; Perrin LS; Forrester K; Hoover RN; Trump BF; Harris CC; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):481-3. PubMed ID: 1302561
[TBL] [Abstract][Full Text] [Related]
2. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
[TBL] [Abstract][Full Text] [Related]
3. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.
Weston A; Ling-Cawley HM; Caporaso NE; Bowman ED; Hoover RN; Trump BF; Harris CC
Carcinogenesis; 1994 Apr; 15(4):583-7. PubMed ID: 7908608
[TBL] [Abstract][Full Text] [Related]
4. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history.
Murata M; Tagawa M; Kimura M; Kimura H; Watanabe S; Saisho H
Carcinogenesis; 1996 Feb; 17(2):261-4. PubMed ID: 8625447
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer, race, and a CYP1A1 genetic polymorphism.
Shields PG; Caporaso NE; Falk RT; Sugimura H; Trivers GE; Trump BF; Hoover RN; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):481-5. PubMed ID: 8220094
[TBL] [Abstract][Full Text] [Related]
6. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
7. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53.
Irarrázabal CE; Rojas C; Aracena R; Márquez C; Gil L
Toxicol Lett; 2003 Sep; 144(1):69-76. PubMed ID: 12919725
[TBL] [Abstract][Full Text] [Related]
8. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
Weston A; Caporaso NE; Perrin LS; Sugimura H; Tamai S; Krontiris TG; Trump BF; Hoover RN; Harris CC
Environ Health Perspect; 1992 Nov; 98():61-7. PubMed ID: 1486864
[TBL] [Abstract][Full Text] [Related]
9. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
10. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene.
Felley-Bosco E; Weston A; Cawley HM; Bennett WP; Harris CC
Am J Hum Genet; 1993 Sep; 53(3):752-9. PubMed ID: 8352280
[TBL] [Abstract][Full Text] [Related]
11. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
12. p53 codon 72 polymorphism and risk of cervical cancer in UK.
Rosenthal AN; Ryan A; Al-Jehani RM; Storey A; Harwood CA; Jacobs IJ
Lancet; 1998 Sep; 352(9131):871-2. PubMed ID: 9742979
[TBL] [Abstract][Full Text] [Related]
13. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
[TBL] [Abstract][Full Text] [Related]
14. TP53 codon 72 polymorphism and breast cancer in northern Iran.
Kazemi M; Salehi Z; Chakosari RJ
Oncol Res; 2009; 18(1):25-30. PubMed ID: 19911701
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Fontanini G
Oncol Rep; 2008 Mar; 19(3):771-3. PubMed ID: 18288414
[TBL] [Abstract][Full Text] [Related]
16. [Role of the genetic polymorphism of p53 (codon 72) gene in colorectal cancer].
Lima JM; Serafim PV; Silva ID; Forones NM
Arq Gastroenterol; 2006; 43(1):8-13. PubMed ID: 16699611
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.
Weston A; Godbold JH
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):919-26. PubMed ID: 9255581
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relationship between cervical cancer and p53 codon 72 polymorphism].
Qie M; Zhang Y; Wu J
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):274-5. PubMed ID: 12575207
[TBL] [Abstract][Full Text] [Related]
19. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.
Pierce LM; Sivaraman L; Chang W; Lum A; Donlon T; Seifried A; Wilkens LR; Lau AF; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1199-204. PubMed ID: 11097227
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
